Modou Jobarteh, PhD’s Post

In the past two days I posted a question whether those two papers are duplicate or not: 1-OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 tria 2-OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial ==>Despite that both papers have ~ the same authors, treatment arms (dosage, timing,..etc) and recruitment period --- they are not considered duplicate population. When you go to their protocol published in clinicaltrials.gov, you will find that the trial location is different (attached screen shot) Note that the same trial could have two different registration numbers See https://lnkd.in/d2gi9SaD So you have to check every paper well before taking the exclusion decision especially when you have small number of included papers. #research #medicalresearch #publication #duplicate #systematicreview #metaanalysis #publichealth #editor

🚨10 days left 🚨 Did you miss the abstract deadline for ESPE 2024 and still want to submit your work? Late breaking abstracts are now open for submissions, and we want to see your research! If accepted, your work will be accessible to thousands of clinicians and researchers. Sharing an abstract will help progress your work, get useful feedback from colleagues, and boost your presentation skills. Submission deadline: 15 July 2024

Do you have an opinion on how clinical trial results are shared with patients and the public? Or experience in either communicating or receiving research findings? Sanjana Choudhury is looking for participants to interview for her doctoral research. Email Sanjana ([email protected]) directly to learn more, and see further details here: https://lnkd.in/g_kpYfRk PS - the 'researcher in a trial' inclusion criteria includes #MedComms! #PatientAndPublicInvolvement #PatientEngagement #LaySummaries #EUCTR #PlainLanguageSummaries #ResearchTransparency

Done certification course in Advance diploma in clinical research from clini Launch institute Benglore

✨ Day 7 of the Translator’s Advent Calendar: “Final PICO” The term “final PICO” is essential in clinical research and medical translation. It’s a format used to frame and answer a clinical research question, ensuring that studies are structured and results are reliable. In translation, understanding the nuances of such terms is crucial for accurately conveying research findings across languages. Mastering terms such as PICO helps ensure precision and clarity in medical documents, ultimately supporting global health initiatives. #PICO #ClinicalResearch #ResearchMethodology #Translation #TranslatorAdventCalendar #MedicalTranslation #Terminology

Highlighting this work led by my colleague, Will Cragg, about developing resources for participants who withdraw from clinical trials. Stopping participation can be a tough process for participants. People have reported feeling 'abandoned', or find it difficult to communicate reasons for stopping participation, or communication from research staff about what happens as a result of stopping participation, makes it more difficult. But the work hadn't really been explored in depth, and we found that sometimes participants can be excluded from important communications like study results without clear justification. A co-developed resource to provide support to research participants who stop taking part was produced. I really enjoyed being involved, particularly being led by Will and watching him manage this project with a group of public contributors whose experience and skills were essential to informing the direction of the work. Have a read and check out the PeRSEVERE website, developed by Will, for guidance and resources for handling end of participation https://lnkd.in/e__Fr-9U Full paper here: https://lnkd.in/e4MJn39S #trialconduct #ppie #clinicaltrials #research

#EditorsChoice   📝 Vericiguat in Heart Failure: Characteristics, Scientific Evidence and Potential Clinical Applications — Vannuccini, Campora, Barilli and Palazzuoli.   In this paper, the authors aim to analyze the characteristics of vericiguat, review new evidence from recent studies, and discuss the next steps for consolidating its clinical use, with a focus on clinical trial literature.   Full text is available 👇 https://lnkd.in/duNJdVtz   #medicine #health #research #science

What makes working at Headlands Research so rewarding? According to Dr. Siddharth Kaul, Investigator at Clinical Research Professionals (CRP), a Headlands Research site, it's all about being a part of cutting-edge research. Learn more about Dr. Kaul's work at CRP, and the family approach that the team at CRP takes for our participants in this video. #HeadlandsResearch #ClinicalTrialSites #ClinicalTrials https://lnkd.in/e67TNnJh

Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guideline https://lnkd.in/dWypguRG

Most clinical research is observational. And that's maybe a good thing. Find out more below. #academicpublishing #reportingguidelines #scientificwriting #medicalwriting #peerreviewweek #openacessweek